Literature DB >> 36068846

The mechanisms of immune response and evasion by the main SARS-CoV-2 variants.

Qiuli Chen1, Jiawei Zhang2, Peter Wang1, Zuyong Zhang3.   

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. SARS-CoV-2 carries a unique group of mutations, and the transmission of the virus has led to the emergence of other mutants such as Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Kappa (B.1.617.1), Delta (B.1.617.2) and Omicron (B.1.1.529). The advent of a vaccine has raised hopes of ending the pandemic. However, the mutation variants of SARS-CoV-2 have raised concerns about the effectiveness of vaccines because the data showed that the vaccine was less effective against mutation variants compared to the previous variants. Mutation variants could easily mutate the N-segment structure and receptor domain of its spike glycoprotein (S) protein to escape antibody recognition. Therefore, it is vital to understand the potential immune response and evasion mechanism of SARS-CoV-2 variants. In this review, immune response and evasion mechanisms of several SARS-CoV-2 variants are described, which could provide some helpful advice for future vaccines.
© 2022 The Authors.

Entities:  

Keywords:  Immunology; public health; virology

Year:  2022        PMID: 36068846      PMCID: PMC9436868          DOI: 10.1016/j.isci.2022.105044

Source DB:  PubMed          Journal:  iScience        ISSN: 2589-0042


  111 in total

1.  Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.

Authors:  Aekkachai Tuekprakhon; Rungtiwa Nutalai; Aiste Dijokaite-Guraliuc; Daming Zhou; Helen M Ginn; Muneeswaran Selvaraj; Chang Liu; Alexander J Mentzer; Piyada Supasa; Helen M E Duyvesteyn; Raksha Das; Donal Skelly; Thomas G Ritter; Ali Amini; Sagida Bibi; Sandra Adele; Sile Ann Johnson; Bede Constantinides; Hermione Webster; Nigel Temperton; Paul Klenerman; Eleanor Barnes; Susanna J Dunachie; Derrick Crook; Andrew J Pollard; Teresa Lambe; Philip Goulder; Neil G Paterson; Mark A Williams; David R Hall; Elizabeth E Fry; Jiandong Huo; Juthathip Mongkolsapaya; Jingshan Ren; David I Stuart; Gavin R Screaton
Journal:  Cell       Date:  2022-06-09       Impact factor: 66.850

2.  Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Authors:  Yiska Weisblum; Fabian Schmidt; Fengwen Zhang; Justin DaSilva; Daniel Poston; Julio Cc Lorenzi; Frauke Muecksch; Magdalena Rutkowska; Hans-Heinrich Hoffmann; Eleftherios Michailidis; Christian Gaebler; Marianna Agudelo; Alice Cho; Zijun Wang; Anna Gazumyan; Melissa Cipolla; Larry Luchsinger; Christopher D Hillyer; Marina Caskey; Davide F Robbiani; Charles M Rice; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Elife       Date:  2020-10-28       Impact factor: 8.140

3.  Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.

Authors:  Tyler N Starr; Allison J Greaney; Amin Addetia; William W Hannon; Manish C Choudhary; Adam S Dingens; Jonathan Z Li; Jesse D Bloom
Journal:  Science       Date:  2021-01-25       Impact factor: 47.728

4.  Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.

Authors:  Nicole L Washington; Karthik Gangavarapu; Mark Zeller; Alexandre Bolze; Elizabeth T Cirulli; Kelly M Schiabor Barrett; Brendan B Larsen; Catelyn Anderson; Simon White; Tyler Cassens; Sharoni Jacobs; Geraint Levan; Jason Nguyen; Jimmy M Ramirez; Charlotte Rivera-Garcia; Efren Sandoval; Xueqing Wang; David Wong; Emily Spencer; Refugio Robles-Sikisaka; Ezra Kurzban; Laura D Hughes; Xianding Deng; Candace Wang; Venice Servellita; Holly Valentine; Peter De Hoff; Phoebe Seaver; Shashank Sathe; Kimberly Gietzen; Brad Sickler; Jay Antico; Kelly Hoon; Jingtao Liu; Aaron Harding; Omid Bakhtar; Tracy Basler; Brett Austin; Duncan MacCannell; Magnus Isaksson; Phillip G Febbo; David Becker; Marc Laurent; Eric McDonald; Gene W Yeo; Rob Knight; Louise C Laurent; Eileen de Feo; Michael Worobey; Charles Y Chiu; Marc A Suchard; James T Lu; William Lee; Kristian G Andersen
Journal:  Cell       Date:  2021-03-30       Impact factor: 41.582

5.  Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2.

Authors:  John P Evans; Cong Zeng; Panke Qu; Julia Faraone; Yi-Min Zheng; Claire Carlin; Joseph S Bednash; Tongqing Zhou; Gerard Lozanski; Rama Mallampalli; Linda J Saif; Eugene M Oltz; Peter J Mohler; Kai Xu; Richard J Gumina; Shan-Lu Liu
Journal:  Cell Host Microbe       Date:  2022-04-25       Impact factor: 31.316

Review 6.  Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.

Authors:  Stephen A Klassen; Jonathon W Senefeld; Katherine A Senese; Patrick W Johnson; Chad C Wiggins; Sarah E Baker; Noud van Helmond; Katelyn A Bruno; Liise-Anne Pirofski; Shmuel Shoham; Brenda J Grossman; Jeffrey P Henderson; R Scott Wright; DeLisa Fairweather; Nigel S Paneth; Rickey E Carter; Arturo Casadevall; Michael J Joyner
Journal:  Front Med (Lausanne)       Date:  2021-06-07

7.  Omicron: a drug developer's perspective.

Authors:  Fang Flora Fang; Pei-Yong Shi
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

8.  Evolution of enhanced innate immune evasion by SARS-CoV-2.

Authors:  Lucy G Thorne; Mehdi Bouhaddou; Ann-Kathrin Reuschl; Lorena Zuliani-Alvarez; Ben Polacco; Adrian Pelin; Jyoti Batra; Matthew V X Whelan; Myra Hosmillo; Andrea Fossati; Roberta Ragazzini; Irwin Jungreis; Manisha Ummadi; Ajda Rojc; Jane Turner; Marie L Bischof; Kirsten Obernier; Hannes Braberg; Margaret Soucheray; Alicia Richards; Kuei-Ho Chen; Bhavya Harjai; Danish Memon; Joseph Hiatt; Romel Rosales; Briana L McGovern; Aminu Jahun; Jacqueline M Fabius; Kris White; Ian G Goodfellow; Yasu Takeuchi; Paola Bonfanti; Kevan Shokat; Natalia Jura; Klim Verba; Mahdad Noursadeghi; Pedro Beltrao; Manolis Kellis; Danielle L Swaney; Adolfo García-Sastre; Clare Jolly; Greg J Towers; Nevan J Krogan
Journal:  Nature       Date:  2021-12-23       Impact factor: 69.504

9.  Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

Authors:  Jamie Lopez Bernal; Nick Andrews; Charlotte Gower; Eileen Gallagher; Ruth Simmons; Simon Thelwall; Julia Stowe; Elise Tessier; Natalie Groves; Gavin Dabrera; Richard Myers; Colin N J Campbell; Gayatri Amirthalingam; Matt Edmunds; Maria Zambon; Kevin E Brown; Susan Hopkins; Meera Chand; Mary Ramsay
Journal:  N Engl J Med       Date:  2021-07-21       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.